Results 11 to 20 of about 58,711 (259)

Impact of COVID-19 Pandemic in Antibiotic Consumption in Navarre (Spain): An Interrupted Time Series Analysis

Antibiotics, 2023
On 11 March 2020, the World Health Organization declared coronavirus disease 19 (COVID-19) a global pandemic. This exceptional situation changed the world not only in terms of mortality and morbidity, but also in terms of epidemiology and health system ...
Natalia Alzueta, Amaya Echeverría, Patricia García, Lorea Sanz, Alberto Gil-Setas, Xabier Beristain, Pablo Aldaz, Javier Garjón   +7 more
doaj   +2 more sources

Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023
Background As COVID-19 vaccine effectiveness against SARS-CoV-2 infection was lower for cases of the Omicron vs the Delta variant, understanding the effect of vaccination in reducing risk of hospitalisation and severe disease among COVID-19 cases is ...
I. Martínez-Baz, Camino Trobajo-Sanmartín, Ana Miqueleiz, I. Casado, A. Navascués, C. Burgui, C. Ezpeleta, J. Castilla, M. Guevara   +8 more
semanticscholar   +1 more source

Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023

Vaccines, 2023
We estimated influenza vaccine effectiveness (IVE) in preventing outpatient and hospitalized cases in the 2022–2023 season. A test-negative design included a representative sample of outpatients and all hospitalized patients with influenza-like illness ...
I. Martínez-Baz, Miguel Fernández-Huerta, A. Navascués, F. Pozo, Camino Trobajo-Sanmartín, I. Casado, Aitziber Echeverría, C. Ezpeleta, J. Castilla   +8 more
semanticscholar   +1 more source

Absent in (life and) death? Examining the tombs of Navarre’s regnant queens and the shaping of their memory

Journal of Medieval Iberian Studies, 2023
Navarre has long been seen as a liminal state, torn between influence and interference from its French and Iberian neighbors. The five regnant queens of Navarre exemplify this situation through their own lives which saw them pulled politically and even ...
Elena Woodacre
semanticscholar   +1 more source

Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022
In Navarre, Spain, in May 2022, the seroprevalence of anti-nucleocapsid (N) and anti-spike (S) antibodies of SARS-CoV-2 was 58.9% and 92.7%, respectively.
J. Castilla, O. Lecea, C. Martín Salas, D. Quílez, Ana Miqueleiz, Camino Trobajo-Sanmartín, A. Navascués, I. Martínez-Baz, I. Casado, C. Burgui, N. Egüés, G. Ezpeleta, C. Ezpeleta   +12 more
semanticscholar   +1 more source

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021
COVID-19 vaccine effectiveness was evaluated in close contacts of cases diagnosed during January–April 2021. Among 20,961 contacts, 7,240 SARS-CoV-2 infections were confirmed, with 5,467 being symptomatic and 559 leading to hospitalisations.
I. Martínez-Baz, Ana Miqueleiz, Itziar Casado, A. Navascués, Camino Trobajo-Sanmartín, C. Burgui, Marcela Guevara, C. Ezpeleta, J. Castilla   +8 more
semanticscholar   +1 more source

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021
COVID-19 vaccine effectiveness by product (two doses Comirnaty, Spikevax or Vaxzevria and one of Janssen), against infection ranged from 50% (95% CI: 42 to 57) for Janssen to 86% (70 to 93) for Vaxzevria-Comirnaty combination; among ≥ 60 year-olds, from ...
I. Martínez-Baz, Camino Trobajo-Sanmartín, Ana Miqueleiz, M. Guevara, Miguel Fernández-Huerta, C. Burgui, I. Casado, M. Portillo, A. Navascués, C. Ezpeleta, J. Castilla   +10 more
semanticscholar   +1 more source

Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain

Orphanet Journal of Rare Diseases, 2021
Background There is great heterogeneity on geographic and temporary Huntington disease (HD) epidemiological estimates. Most research studies of rare diseases, including HD, use health information systems (HIS) as data sources. This study investigates the
E. Vicente, Ainara Ruiz de Sabando, Fermín García, I. Gastón, E. Ardanaz, M. Ramos-Arroyo   +5 more
semanticscholar   +1 more source

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022
Compared with individuals unvaccinated in the current and three previous influenza seasons, in 2021/22, influenza vaccine effectiveness at primary care level was 37% (95% CI: 16 to 52) for current season vaccination, regardless of previous doses, and 35%
I. Martínez-Baz, I. Casado, Ana Miqueleiz, A. Navascués, F. Pozo, Camino Trobajo-Sanmartín, E. Albéniz, F. Elía, C. Burgui, Miguel Fernández-Huerta, C. Ezpeleta, J. Castilla   +11 more
semanticscholar   +1 more source

BETWEEN SERVICE TO THE KING AND THE BLACK LEGEND: ÁNGEL DE COSTAFORT (FL. 1362-1366), DOCTOR TO CHARLES II OF NAVARRE.

Acta Medico-Historica Adriatica, 2022
https://doi.org/10.31952/amha.20.1.1 At the trial of Jacques de Rue, the chamberlain of King Charles II of Navarre, after he was arrested in France (March 1378), we learn that the doctor Ángel de Costafort was implicated in several of the king of Navarre'
Fernando Serrano Larráyoz
semanticscholar   +1 more source